The effect of glucocorticoids on mortality in severe COVID-19 patients: Evidence from 13 studies involving 6612 cases

BACKGROUND: Since the start of the coronavirus disease 2019 (COVID-19) pandemic, there is an urgent need for effective therapies for patients with COVID-19. In this study, we aimed to assess the therapeutic efficacy of glucocorticoids in severe COVID-19. METHODS: A systematic literature search was p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Guang-Qing, Jiang, Zhong-Hui, Yang, Zhong-Bin, Jiang, Shi-Qin, Quan, Xiao-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500595/
https://www.ncbi.nlm.nih.gov/pubmed/34622840
http://dx.doi.org/10.1097/MD.0000000000027373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500595/
https://www.ncbi.nlm.nih.gov/pubmed/34622840
http://dx.doi.org/10.1097/MD.0000000000027373

Ejemplares similares